<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>S3434</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.fronterpagebillhead
	{mso-style-name:fronterpagebillhead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FPHangingAnAct, li.FPHangingAnAct, div.FPHangingAnAct
	{mso-style-name:FPHangingAnAct;
	mso-style-link:"FPHangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.4in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.FPHangingAnActChar
	{mso-style-name:"FPHangingAnAct Char";
	mso-style-link:FPHangingAnAct;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.0in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.3in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>SENATE, No. 3434 </p>

<p class=bpuWpGraphic><b><span style='font-size:32.0pt;line-height:120%;
font-family:"Arial",sans-serif;letter-spacing:0pt'>STATE OF NEW JERSEY</span></b></p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>INTRODUCED JUNE 10, 2024</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:11.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Senator  JOSEPH F. VITALE</p>

<p class=bpuSponsor>District 19 (Middlesex)</p>

<p class=bpuSponsor>Senator  SHIRLEY K. TURNER</p>

<p class=bpuSponsor>District 15 (Hunterdon and Mercer)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Clarifies coverage requirements for health insurers
of over-the-counter contraceptive drugs. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     As introduced.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif;
letter-spacing:.2pt'><br clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span><span
class=HangingAnActChar> </span>concerning health insurance coverage for
contraceptives and amending P.L.2005, c.251 and P.L.2021, c.376.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     1.    Section 1 of P.L.2005,
c.251 (C.17:48-6ee) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     1.    a.  A hospital service
corporation that provides hospital or medical expense benefits shall provide
coverage under every contract delivered, issued, executed or renewed in this
State or approved for issuance or renewal in this State by the Commissioner of Banking
and Insurance, on or after the effective date of this act, for expenses
incurred in the purchase of prescription <u>and over-the-counter</u> female
contraceptives, and the following services, drugs, devices, products, and
procedures on an in-network basis:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   Any contraceptive drug,
device or product approved by the United States Food and Drug Administration,
which coverage shall be subject to all of the following conditions:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   If there is a
therapeutic equivalent of a <u>prescription</u> contraceptive drug, device or
product approved by the United States Food and Drug Administration, coverage
shall be provided for either the requested <u>prescription</u> contraceptive
drug, device or product or for one or more therapeutic equivalents of the
requested <u>prescription</u> drug, device or product.</p>

<p class=MsoNormal style='line-height:150%'>     (b)   Coverage shall be
provided without a prescription <u>or provider order</u> for all contraceptive
drugs available for over-the-counter sale that are approved by the United
States Food and Drug Administration.</p>

<p class=MsoNormal style='line-height:150%'>     (c)   Coverage shall be provided
without any infringement upon a subscriber's choice of contraception <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>and medical<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><u>.  Medical </u>necessity
shall be determined by the provider for covered <u>prescription</u>
contraceptive drugs, devices or other products approved by the United States
Food and Drug Administration.  <u>Medical necessity for over-the-counter
contraceptive drugs shall be deemed to be present.</u></p>

<p class=MsoNormal style='line-height:150%'>     (2)   Voluntary male and
female sterilization.</p>

<p class=MsoNormal style='line-height:150%'>     (3)   Patient education and
counseling on contraception.</p>

<p class=MsoNormal style='line-height:150%'>     (4)   Services related to the
administration and monitoring of drugs, devices, products and services required
under this section, including but not limited to:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   Management of side
effects;</p>

<p class=MsoNormal style='line-height:150%'>     (b)   Counseling for continued
adherence to a prescribed regimen;</p>

<p class=MsoNormal style='line-height:150%'>     (c)   Device insertion and
removal;</p>

<p class=MsoNormal style='line-height:150%'>     (d)   Provision of alternative
contraceptive drugs, devices or products deemed medically appropriate in the
judgment of the subscriber's health care provider; and</p>

<p class=MsoNormal style='line-height:150%'>     (e)   Diagnosis and treatment
services provided pursuant to, or as a follow-up to, a service required under
this section.</p>

<p class=MsoNormal style='line-height:150%'>     b.    The coverage provided
shall include prescriptions for dispensing contraceptives for:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   (Deleted by amendment,
P.L.2021, c.376)</p>

<p class=MsoNormal style='line-height:150%'>     (2)   up to a 12-month period
at one time.</p>

<p class=MsoNormal style='line-height:150%'>     c.     (1)  Except as provided
in paragraph (2) of this subsection, the benefits shall be provided to the same
extent as for any other service, drug, device, product, or procedure under the
contract, except no deductible, coinsurance, copayment, or any other
cost-sharing requirement on the coverage shall be imposed.  <u>Point-of-sale
coverage for over-the-counter female contraceptives shall be provided without
cost-sharing or medical management restrictions.</u></p>

<p class=MsoNormal style='line-height:150%'>     (2)   In the case of a
high-deductible health plan, benefits for male sterilization or male
contraceptives shall be provided at the lowest deductible and other
cost-sharing permitted for a high-deductible health plan under section
223(c)(2)(A) of the Internal Revenue Code (26 U.S.C. s.223).</p>

<p class=MsoNormal style='line-height:150%'>     d.    This section shall apply
to those contracts in which the hospital service corporation has reserved the
right to change the premium.</p>

<p class=MsoNormal style='line-height:150%'>     e.     Nothing in this section
shall limit coverage of any additional preventive service for women, as
identified or recommended by the United States Preventive Services Task Force
or the Health Resources and Services Administration of the United States
Department of Health and Human Services pursuant to the provisions of 42 U.S.C.
300gg-13.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2021, c.376, s.1)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     2.    Section 2 of P.L.2005,
c.251 (C.17:48A-7bb) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     2.    a.  A medical service
corporation that provides hospital or medical expense benefits shall provide
coverage under every contract delivered, issued, executed or renewed in this
State or approved for issuance or renewal in this State by the Commissioner of
Banking and Insurance, on or after the effective date of this act, for expenses
incurred in the purchase of prescription <u>and over-the-counter</u> female
contraceptives, and the following services, drugs, devices, products, and
procedures on an in-network basis:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   Any contraceptive drug,
device or product approved by the United States Food and Drug Administration,
which coverage shall be subject to all of the following conditions:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   If there is a
therapeutic equivalent of a <u>prescription</u> contraceptive drug, device or
product approved by the United States Food and Drug Administration, coverage
shall be provided for either the requested <u>prescription</u> contraceptive
drug, device or product or for one or more therapeutic equivalents of the
requested <u>prescription</u> drug, device or product.</p>

<p class=MsoNormal style='line-height:150%'>     (b)   Coverage shall be
provided without a prescription <u>or provider order</u> for all contraceptive
drugs available for over-the-counter sale that are approved by the United
States Food and Drug Administration.</p>

<p class=MsoNormal style='line-height:150%'>     (c)   Coverage shall be provided
without any infringement upon a subscriber's choice of contraception <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>and medical<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><u>.  Medical </u>necessity
shall be determined by the provider for covered <u>prescription</u>
contraceptive drugs, devices or other products approved by the United States
Food and Drug Administration.  <u>Medical necessity for over-the-counter
contraceptive drugs shall be deemed to be present.</u></p>

<p class=MsoNormal style='line-height:150%'>     (2)   Voluntary male and
female sterilization.</p>

<p class=MsoNormal style='line-height:150%'>     (3)   Patient education and
counseling on contraception.</p>

<p class=MsoNormal style='line-height:150%'>     (4)   Services related to the
administration and monitoring of drugs, devices, products and services required
under this section, including but not limited to:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   Management of side
effects;</p>

<p class=MsoNormal style='line-height:150%'>     (b)   Counseling for continued
adherence to a prescribed regimen;</p>

<p class=MsoNormal style='line-height:150%'>     (c)   Device insertion and
removal;</p>

<p class=MsoNormal style='line-height:150%'>     (d)   Provision of alternative
contraceptive drugs, devices or products deemed medically appropriate in the
judgment of the subscriber's health care provider; and</p>

<p class=MsoNormal style='line-height:150%'>     (e)   Diagnosis and treatment
services provided pursuant to, or as a follow-up to, a service required under
this section. </p>

<p class=MsoNormal style='line-height:150%'>     b.    The coverage provided
shall include prescriptions for dispensing contraceptives for:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   (Deleted by amendment,
P.L.2021, c.376)</p>

<p class=MsoNormal style='line-height:150%'>     (2)   up to a 12-month period
at one time.</p>

<p class=MsoNormal style='line-height:150%'>     c.     (1)  Except as provided
in paragraph (2) of this subsection, the benefits shall be provided to the same
extent as for any other service, drug, device, product, or procedure under the
contract, except no deductible, coinsurance, copayment, or any other
cost-sharing requirement on the coverage shall be imposed.  <u>Point-of-sale
coverage for over-the-counter female contraceptives shall be provided without
cost-sharing or medical management restrictions.</u></p>

<p class=MsoNormal style='line-height:150%'>     (2)   In the case of a
high-deductible health plan, benefits for male sterilization or male
contraceptives shall be provided at the lowest deductible and other
cost-sharing permitted for a high-deductible health plan under section
223(c)(2)(A) of the Internal Revenue Code (26 U.S.C. s.223).</p>

<p class=MsoNormal style='line-height:150%'>     d.    This section shall apply
to those contracts in which the medical service corporation has reserved the
right to change the premium.</p>

<p class=MsoNormal style='line-height:150%'>     e.     Nothing in this section
shall limit coverage of any additional preventive service for women, as
identified or recommended by the United States Preventive Services Task Force
or the Health Resources and Services Administration of the United States
Department of Health and Human Services pursuant to the provisions of 42 U.S.C.
300gg-13.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2021, c.376, s.2)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3.    Section 3 of P.L.2005,
c.251 (C.17:48E-35.29) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     3.    a.  A health service
corporation that provides hospital or medical expense benefits shall provide
coverage under every contract delivered, issued, executed or renewed in this
State or approved for issuance or renewal in this State by the Commissioner of
Banking and Insurance, on or after the effective date of this act, for expenses
incurred in the purchase of prescription <u>and over-the-counter</u> female
contraceptives, and the following services, drugs, devices, products, and
procedures on an in-network basis:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   Any contraceptive drug,
device or product approved by the United States Food and Drug Administration,
which coverage shall be subject to all of the following conditions:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   If there is a
therapeutic equivalent of a <u>prescription</u> contraceptive drug, device or
product approved by the United States Food and Drug Administration, coverage
shall be provided for either the requested <u>prescription</u> contraceptive
drug, device or product or for one or more therapeutic equivalents of the
requested <u>prescription</u> drug, device or product.</p>

<p class=MsoNormal style='line-height:150%'>     (b)   Coverage shall be
provided without a prescription <u>or provider</u> <u>order</u> for all
contraceptive drugs available for over-the-counter sale that are approved by
the United States Food and Drug Administration.</p>

<p class=MsoNormal style='line-height:150%'>     (c)   Coverage shall be provided
without any infringement upon a subscriber's choice of contraception <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>and medical<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><u>.  Medical </u>necessity
shall be determined by the provider for covered <u>prescription</u>
contraceptive drugs, devices or other products approved by the United States
Food and Drug Administration.  <u>Medical necessity for over-the-counter
contraceptive drugs shall be deemed to be present.</u></p>

<p class=MsoNormal style='line-height:150%'>     (2)   Voluntary male and
female sterilization.</p>

<p class=MsoNormal style='line-height:150%'>     (3)   Patient education and
counseling on contraception.</p>

<p class=MsoNormal style='line-height:150%'>     (4)   Services related to the
administration and monitoring of drugs, devices, products and services required
under this section, including but not limited to:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   Management of side
effects;</p>

<p class=MsoNormal style='line-height:150%'>     (b)   Counseling for continued
adherence to a prescribed regimen;</p>

<p class=MsoNormal style='line-height:150%'>     (c)   Device insertion and
removal;</p>

<p class=MsoNormal style='line-height:150%'>     (d)   Provision of alternative
contraceptive drugs, devices or products deemed medically appropriate in the
judgment of the subscriber's health care provider; and</p>

<p class=MsoNormal style='line-height:150%'>     (e)   Diagnosis and treatment
services provided pursuant to, or as a follow-up to, a service required under
this section. </p>

<p class=MsoNormal style='line-height:150%'>     b.    The coverage provided
shall include prescriptions for dispensing contraceptives for:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   (Deleted by amendment,
P.L.2021, c.376)</p>

<p class=MsoNormal style='line-height:150%'>     (2)   up to a 12-month period
at one time.</p>

<p class=MsoNormal style='line-height:150%'>     c.     (1)  Except as provided
in paragraph (2) of this subsection, the benefits shall be provided to the same
extent as for any other service, drug, device, product, or procedure under the
contract, except no deductible, coinsurance, copayment, or any other
cost-sharing requirement on the coverage shall be imposed.  <u>Point-of-sale
coverage for over-the-counter female contraceptives shall be provided without
cost-sharing or medical management restrictions.</u></p>

<p class=MsoNormal style='line-height:150%'>     (2)    In the case of a
high-deductible health plan, benefits for male sterilization or male
contraceptives shall be provided at the lowest deductible and other
cost-sharing permitted for a high-deductible health plan under section
223(c)(2)(A) of the Internal Revenue Code (26 U.S.C. s.223).</p>

<p class=MsoNormal style='line-height:150%'>     d.    This section shall apply
to those contracts in which the health service corporation has reserved the
right to change the premium.</p>

<p class=MsoNormal style='line-height:150%'>     e.     Nothing in this section
shall limit coverage of any additional preventive service for women, as
identified or recommended by the United States Preventive Services Task Force
or the Health Resources and Services Administration of the United States
Department of Health and Human Services pursuant to the provisions of 42 U.S.C.
300gg-13.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2021, c.376, s.3)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     4.    Section 4 of P.L.2005,
c.251 (C.17B:27-46.1ee) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     4.    a.  A group health
insurer that provides hospital or medical expense benefits shall provide
coverage under every policy delivered, issued, executed or renewed in this
State or approved for issuance or renewal in this State by the Commissioner of
Banking and Insurance, on or after the effective date of this act, for expenses
incurred in the purchase of prescription <u>and over-the-counter</u> female
contraceptives, and the following services, drugs, devices, products, and
procedures on an in-network basis:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   Any contraceptive drug,
device or product approved by the United States Food and Drug Administration,
which coverage shall be subject to all of the following conditions:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   If there is a
therapeutic equivalent of a <u>prescription</u> contraceptive drug, device or product
approved by the United States Food and Drug Administration, coverage shall be
provided for either the requested <u>prescription</u> contraceptive drug,
device or product or for one or more therapeutic equivalents of the requested <u>prescription</u>
drug, device or product.</p>

<p class=MsoNormal style='line-height:150%'>     (b)   Coverage shall be
provided without a prescription <u>or provider order</u> for all contraceptive
drugs available for over-the-counter sale that are approved by the United
States Food and Drug Administration.</p>

<p class=MsoNormal style='line-height:150%'>     (c)   Coverage shall be
provided without any infringement upon a subscriber's choice of contraception <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>and medical<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><u>.  Medical </u>necessity
shall be determined by the provider for covered contraceptive drugs, devices or
other products approved by the United States Food and Drug Administration.  <u>Medical
necessity for over-the-counter contraceptive drugs shall be deemed to be
present.</u> </p>

<p class=MsoNormal style='line-height:150%'>     (2)   Voluntary male and
female sterilization.</p>

<p class=MsoNormal style='line-height:150%'>     (3)   Patient education and
counseling on contraception.</p>

<p class=MsoNormal style='line-height:150%'>     (4)   Services related to the
administration and monitoring of drugs, devices, products and services required
under this section, including but not limited to:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   Management of side
effects;</p>

<p class=MsoNormal style='line-height:150%'>     (b)   Counseling for continued
adherence to a prescribed regimen;</p>

<p class=MsoNormal style='line-height:150%'>     (c)   Device insertion and
removal;</p>

<p class=MsoNormal style='line-height:150%'>     (d)   Provision of alternative
contraceptive drugs, devices or products deemed medically appropriate in the
judgment of the subscriber's health care provider; and</p>

<p class=MsoNormal style='line-height:150%'>     (e)   Diagnosis and treatment
services provided pursuant to, or as a follow-up to, a service required under
this section. </p>

<p class=MsoNormal style='line-height:150%'>     b.    The coverage provided
shall include prescriptions for dispensing contraceptives for:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   (Deleted by amendment,
P.L.2021, c.376)</p>

<p class=MsoNormal style='line-height:150%'>     (2)   up to a 12-month period
at one time.</p>

<p class=MsoNormal style='line-height:150%'>     c.     (1)  Except as provided
in paragraph (2) of this subsection, the benefits shall be provided to the same
extent as for any other service, drug, device, product, or procedure under the
policy, except no deductible, coinsurance, copayment, or any other cost-sharing
requirement on the coverage shall be imposed.  <u>Point-of-sale coverage for
over-the-counter female contraceptives shall be provided without cost-sharing
or medical management restrictions.</u></p>

<p class=MsoNormal style='line-height:150%'>     (2)   In the case of a
high-deductible health plan, benefits for male sterilization or male
contraceptives shall be provided at the lowest deductible and other
cost-sharing permitted for a high-deductible health plan under section
223(c)(2)(A) of the Internal Revenue Code (26 U.S.C. s.223).</p>

<p class=MsoNormal style='line-height:150%'>     d.    This section shall apply
to those policies in which the insurer has reserved the right to change the
premium.</p>

<p class=MsoNormal style='line-height:150%'>     e.     Nothing in this section
shall limit coverage of any additional preventive service for women, as
identified or recommended by the United States Preventive Services Task Force
or the Health Resources and Services Administration of the United States
Department of Health and Human Services pursuant to the provisions of 42 U.S.C.
300gg-13.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2021, c.376, s.4)</p>

<p class=MsoNormal style='line-height:150%'>     5.    Section 5 of P.L.2005,
c.251 (C.17B:26-2.1y) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     5.    a.  An individual health
insurer that provides hospital or medical expense benefits shall provide
coverage under every policy delivered, issued, executed or renewed in this
State or approved for issuance or renewal in this State by the Commissioner of
Banking and Insurance, on or after the effective date of this act, for expenses
incurred in the purchase of prescription <u>and over-the-counter</u> female
contraceptives, and the following services, drugs, devices, products, and
procedures on an in-network basis:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   Any contraceptive drug,
device or product approved by the United States Food and Drug Administration,
which coverage shall be subject to all of the following conditions:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   If there is a
therapeutic equivalent of a <u>prescription</u> contraceptive drug, device or
product approved by the United States Food and Drug Administration, coverage
shall be provided for either the requested <u>prescription</u> contraceptive
drug, device or product or for one or more therapeutic equivalents of the
requested <u>prescription </u>drug, device or product.</p>

<p class=MsoNormal style='line-height:150%'>     (b)   Coverage shall be
provided without a prescription <u>or provider</u> <u>order</u> for all
contraceptive drugs available for over-the-counter sale that are approved by
the United States Food and Drug Administration.</p>

<p class=MsoNormal style='line-height:150%'>     (c)   Coverage shall be
provided without any infringement upon a subscriber's choice of contraception <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>and medical<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><u>.  Medical </u>necessity
shall be determined by the provider for covered <u>prescription</u>
contraceptive drugs, devices or other products approved by the United States
Food and Drug Administration.  <u>Medical necessity for over-the-counter
contraceptive drugs shall be deemed to be present.</u></p>

<p class=MsoNormal style='line-height:150%'>     (2)   Voluntary male and
female sterilization.</p>

<p class=MsoNormal style='line-height:150%'>     (3)   Patient education and
counseling on contraception.</p>

<p class=MsoNormal style='line-height:150%'>     (4)   Services related to the
administration and monitoring of drugs, devices, products and services required
under this section, including but not limited to:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   Management of side
effects;</p>

<p class=MsoNormal style='line-height:150%'>     (b)   Counseling for continued
adherence to a prescribed regimen;</p>

<p class=MsoNormal style='line-height:150%'>     (c)   Device insertion and
removal;</p>

<p class=MsoNormal style='line-height:150%'>     (d)   Provision of alternative
contraceptive drugs, devices or products deemed medically appropriate in the
judgment of the subscriber's health care provider; and</p>

<p class=MsoNormal style='line-height:150%'>     (e)   Diagnosis and treatment
services provided pursuant to, or as a follow-up to, a service required under
this section. </p>

<p class=MsoNormal style='line-height:150%'>     b.    The coverage provided
shall include prescriptions for dispensing contraceptives for:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   (Deleted by amendment,
P.L.2021, c.376)</p>

<p class=MsoNormal style='line-height:150%'>     (2)   up to a 12-month period
at one time.</p>

<p class=MsoNormal style='line-height:150%'>     c.     (1)  Except as provided
in paragraph (2) of this subsection, the benefits shall be provided to the same
extent as for any other service, drug, device, product, or procedure under the
policy, except no deductible, coinsurance, copayment, or any other cost-sharing
requirement on the coverage shall be imposed.  <u>Point-of-sale coverage for
over-the-counter female contraceptives shall be provided without cost-sharing
or medical management restrictions.</u></p>

<p class=MsoNormal style='line-height:150%'>     (2)   In the case of a
high-deductible health plan, benefits for male sterilization or male
contraceptives shall be provided at the lowest deductible and other
cost-sharing permitted for a high-deductible health plan under section
223(c)(2)(A) of the Internal Revenue Code (26 U.S.C. s.223).</p>

<p class=MsoNormal style='line-height:150%'>     d.    This section shall apply
to those policies in which the insurer has reserved the right to change the
premium.</p>

<p class=MsoNormal style='line-height:150%'>     e.     Nothing in this section
shall limit coverage of any additional preventive service for women, as
identified or recommended by the United States Preventive Services Task Force
or the Health Resources and Services Administration of the United States
Department of Health and Human Services pursuant to the provisions of 42 U.S.C.
300gg-13.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2021, c.376, s.5)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     6.    Section 6 of P.L.2005,
c.251 (C.26:2J-4.30) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     6.    a.  A certificate of
authority to establish and operate a health maintenance organization in this
State shall not be issued or continued on or after the effective date of this
act for a health maintenance organization, unless the health maintenance
organization provides health care services for prescription <u>and
over-the-counter</u> female contraceptives, and the following services, drugs,
devices, products, and procedures on an in-network basis:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   Any contraceptive drug,
device or product approved by the United States Food and Drug Administration,
which coverage shall be subject to all of the following conditions:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   If there is a
therapeutic equivalent of a <u>prescription</u> contraceptive drug, device or
product approved by the United States Food and Drug Administration, coverage
shall be provided for either the requested <u>prescription</u> contraceptive
drug, device or product or for one or more therapeutic equivalents of the
requested <u>prescription</u> drug, device or product.</p>

<p class=MsoNormal style='line-height:150%'>     (b)   Coverage shall be
provided without a prescription <u>or provider</u> <u>order</u> for all contraceptive
drugs available for over-the-counter sale that are approved by the United
States Food and Drug Administration.</p>

<p class=MsoNormal style='line-height:150%'>     (c)   Coverage shall be
provided without any infringement upon a subscriber's choice of contraception <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>and medical<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><u>.  Medical </u>necessity
shall be determined by the provider for covered <u>prescription</u>
contraceptive drugs, devices or other products approved by the United States
Food and Drug Administration.  <u>Medical necessity for over-the-counter
contraceptive drugs shall be deemed to be present.</u></p>

<p class=MsoNormal style='line-height:150%'>     (2)   Voluntary male and
female sterilization.</p>

<p class=MsoNormal style='line-height:150%'>     (3)   Patient education and
counseling on contraception.</p>

<p class=MsoNormal style='line-height:150%'>     (4)   Services related to the
administration and monitoring of drugs, devices, products and services required
under this section, including but not limited to:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   Management of side
effects;</p>

<p class=MsoNormal style='line-height:150%'>     (b)   Counseling for continued
adherence to a prescribed regimen;</p>

<p class=MsoNormal style='line-height:150%'>     (c)   Device insertion and
removal;</p>

<p class=MsoNormal style='line-height:150%'>     (d)   Provision of alternative
contraceptive drugs, devices or products deemed medically appropriate in the
judgment of the subscriber's health care provider; and</p>

<p class=MsoNormal style='line-height:150%'>     (e)   Diagnosis and treatment
services provided pursuant to, or as a follow-up to, a service required under
this section. </p>

<p class=MsoNormal style='line-height:150%'>     b.    The coverage provided
shall include prescriptions for dispensing contraceptives for:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   (Deleted by amendment,
P.L.2021, c.376)</p>

<p class=MsoNormal style='line-height:150%'>     (2)   up to a 12-month period
at one time.</p>

<p class=MsoNormal style='line-height:150%'>     c.     (1)  Except as provided
in paragraph (2) of this subsection, the health care services shall be provided
to the same extent as for any other service, drug, device, product, or
procedure under the contract, except no deductible, coinsurance, copayment, or
any other cost-sharing requirement on the coverage shall be imposed.  <u>Point-of-sale
coverage for over-the-counter female contraceptives shall be provided without
cost-sharing or medical management restrictions.</u></p>

<p class=MsoNormal style='line-height:150%'>     (2)   In the case of a
high-deductible health plan, benefits for male sterilization or male
contraceptives shall be provided at the lowest deductible and other
cost-sharing permitted for a high-deductible health plan under section
223(c)(2)(A) of the Internal Revenue Code (26 U.S.C. s.223).</p>

<p class=MsoNormal style='line-height:150%'>     d.    The provisions of this
section shall apply to those contracts for health care services by health
maintenance organizations under which the right to change the schedule of
charges for enrollee coverage is reserved. </p>

<p class=MsoNormal style='line-height:150%'>     e.     Nothing in this section
shall limit coverage of any additional preventive service for women, as
identified or recommended by the United States Preventive Services Task Force
or the Health Resources and Services Administration of the United States
Department of Health and Human Services pursuant to the provisions of 42 U.S.C.
300gg-13.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2021, c.376, s.6)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     7.    Section 7 of P.L.2005,
c.251 (C.17B:27A-7.12) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     7.    a.  An individual health
benefits plan required pursuant to section 3 of P.L.1992, c.161 (C.17B:27A-4)
shall provide coverage for expenses incurred in the purchase of prescription <u>and
over-the-counter</u> female contraceptives, and the following services, drugs,
devices, products, and procedures on an in-network basis:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   Any contraceptive drug,
device or product approved by the United States Food and Drug Administration,
which coverage shall be subject to all of the following conditions:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   If there is a therapeutic
equivalent of a <u>prescription </u>contraceptive drug, device or product
approved by the United States Food and Drug Administration, coverage shall be
provided for either the requested <u>prescription</u> contraceptive drug,
device or product or for one or more therapeutic equivalents of the <u>prescription</u>
requested drug, device or product.</p>

<p class=MsoNormal style='line-height:150%'>     (b)   Coverage shall be
provided without a prescription <u>or provider</u> <u>order</u> for all
contraceptive drugs available for over-the-counter sale that are approved by
the United States Food and Drug Administration.</p>

<p class=MsoNormal style='line-height:150%'>     (c)   Coverage shall be
provided without any infringement upon a subscriber's choice of contraception <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>and medical<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><u>.  Medical </u>necessity
shall be determined by the provider for <u>prescription</u> covered
contraceptive drugs, devices or other products approved by the United States
Food and Drug Administration.  <u>Medical necessity for over-the-counter
contraceptive drugs shall be deemed to be present.</u></p>

<p class=MsoNormal style='line-height:150%'>     (2)   Voluntary male and
female sterilization.</p>

<p class=MsoNormal style='line-height:150%'>     (3)   Patient education and
counseling on contraception.</p>

<p class=MsoNormal style='line-height:150%'>     (4)   Services related to the
administration and monitoring of drugs, devices, products and services required
under this section, including but not limited to:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   Management of side
effects;</p>

<p class=MsoNormal style='line-height:150%'>     (b)   Counseling for continued
adherence to a prescribed regimen;</p>

<p class=MsoNormal style='line-height:150%'>     (c)   Device insertion and
removal;</p>

<p class=MsoNormal style='line-height:150%'>     (d)   Provision of alternative
contraceptive drugs, devices or products deemed medically appropriate in the
judgment of the subscriber's health care provider; and</p>

<p class=MsoNormal style='line-height:150%'>     (e)   Diagnosis and treatment
services provided pursuant to, or as a follow-up to, a service required under
this section. </p>

<p class=MsoNormal style='line-height:150%'>     b.    The coverage provided
shall include prescriptions for dispensing contraceptives for:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   (Deleted by amendment,
P.L.2021, c.376)</p>

<p class=MsoNormal style='line-height:150%'>     (2)   up to a 12-month period
at one time.</p>

<p class=MsoNormal style='line-height:150%'>     c.     (1)  Except as provided
in paragraph (2) of this subsection, the benefits shall be provided to the same
extent as for any other service, drug, device, product, or procedure under the
health benefits plan, except no deductible, coinsurance, copayment, or any
other cost-sharing requirement on the coverage shall be imposed.  <u>Point-of-sale
coverage for over-the-counter female contraceptives shall be provided without
cost-sharing or medical management restrictions.</u></p>

<p class=MsoNormal style='line-height:150%'>     (2)   In the case of a
high-deductible health plan, benefits for male sterilization or male
contraceptives shall be provided at the lowest deductible and other
cost-sharing permitted for a high-deductible health plan under section
223(c)(2)(A) of the Internal Revenue Code (26 U.S.C. s.223).</p>

<p class=MsoNormal style='line-height:150%'>     d.    This section shall apply
to all individual health benefits plans in which the carrier has reserved the
right to change the premium.</p>

<p class=MsoNormal style='line-height:150%'>     e.     Nothing in this section
shall limit coverage of any additional preventive service for women, as
identified or recommended by the United States Preventive Services Task Force
or the Health Resources and Services Administration of the United States
Department of Health and Human Services pursuant to the provisions of 42 U.S.C.
300gg-13.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2021, c.376, s.7)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     8.    Section 8 of P.L.2005,
c.251 (C.17B:27A-19.15) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     8.    a.  A small employer
health benefits plan required pursuant to section 3 of P.L.1992, c.162
(C.17B:27A-19) shall provide coverage for expenses incurred in the purchase of
prescription <u>and over-the-counter</u> female contraceptives, and the
following services, drugs, devices, products, and procedures on an in-network
basis:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   Any contraceptive drug,
device or product approved by the United States Food and Drug Administration,
which coverage shall be subject to all of the following conditions:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   If there is a
therapeutic equivalent of a <u>prescription</u> contraceptive drug, device or
product approved by the United States Food and Drug Administration, coverage
shall be provided for either the requested <u>prescription</u> contraceptive
drug, device or product or for one or more therapeutic equivalents of the
requested <u>prescription </u>drug, device or product.</p>

<p class=MsoNormal style='line-height:150%'>     (b)   Coverage shall be
provided without a prescription <u>or provider</u> <u>order</u> for all
contraceptive drugs available for over-the-counter sale that are approved by
the United States Food and Drug Administration.</p>

<p class=MsoNormal style='line-height:150%'>     (c)   Coverage shall be
provided without any infringement upon a subscriber's choice of contraception <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>and medical<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><u>.  Medical </u>necessity
shall be determined by the provider for covered <u>prescription</u>
contraceptive drugs, devices or other products approved by the United States
Food and Drug Administration.  <u>Medical necessity for over-the-counter
contraceptive drugs shall be deemed to be present.</u></p>

<p class=MsoNormal style='line-height:150%'>     (2)   Voluntary male and
female sterilization.</p>

<p class=MsoNormal style='line-height:150%'>     (3)   Patient education and
counseling on contraception.</p>

<p class=MsoNormal style='line-height:150%'>     (4)   Services related to the
administration and monitoring of drugs, devices, products and services required
under this section, including but not limited to:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   Management of side
effects;</p>

<p class=MsoNormal style='line-height:150%'>     (b)   Counseling for continued
adherence to a prescribed regimen;</p>

<p class=MsoNormal style='line-height:150%'>     (c)   Device insertion and
removal;</p>

<p class=MsoNormal style='line-height:150%'>     (d)   Provision of alternative
contraceptive drugs, devices or products deemed medically appropriate in the
judgment of the subscriber's health care provider; and</p>

<p class=MsoNormal style='line-height:150%'>     (e)   Diagnosis and treatment
services provided pursuant to, or as a follow-up to, a service required under
this section. </p>

<p class=MsoNormal style='line-height:150%'>     b.    The coverage provided
shall include prescriptions for dispensing contraceptives for:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   (Deleted by amendment,
P.L.2021, c.376)</p>

<p class=MsoNormal style='line-height:150%'>     (2)   up to a 12-month period
at one time.</p>

<p class=MsoNormal style='line-height:150%'>     c.     (1)  Except as provided
in paragraph (2) of this subsection, the benefits shall be provided to the same
extent as for any other service, drug, device, product, or procedure under the
health benefits plan, except no deductible, coinsurance, copayment, or any
other cost-sharing requirement on the coverage shall be imposed.  <u>Point-of-sale
coverage for over-the-counter female contraceptives shall be provided without
cost-sharing or medical management restrictions.</u></p>

<p class=MsoNormal style='line-height:150%'>     (2)   In the case of a
high-deductible health plan, benefits for male sterilization or male
contraceptives shall be provided at the lowest deductible and other
cost-sharing permitted for a high-deductible health plan under section
223(c)(2)(A) of the Internal Revenue Code (26 U.S.C. s.223).</p>

<p class=MsoNormal style='line-height:150%'>     d.    This section shall apply
to all small employer health benefits plans in which the carrier has reserved
the right to change the premium.</p>

<p class=MsoNormal style='line-height:150%'>     e.     Nothing in this section
shall limit coverage of any additional preventive service for women, as
identified or recommended by the United States Preventive Services Task Force
or the Health Resources and Services Administration of the United States
Department of Health and Human Services pursuant to the provisions of 42 U.S.C.
300gg-13.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2021, c.376, s.8)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     9.    Section 11 of P.L.2021,
c.376 (C.30:4D-6s) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     11.  Coverage for family
planning services under the State Medicaid program <u>administered by the State
Medicaid agency or through contract with a Medicaid managed care organization <span
style='color:#222222;background:white'>and other programs administered by the
Department of Human<b> </b>Services that provide benefits for contraceptives,
including but not limited to PlanFirst, Cover All Kids, and the Supplemental
Prenatal and Contraceptive Program,</span></u><span style='font-family:"Arial",sans-serif;
color:#222222;background:white'> </span>shall include prescriptions for dispensing
contraceptives for up to a 12-month period at one time.  <u>Coverage shall also
include over-the-counter contraceptives and pharmacy-authorized
self-administered hormonal contraceptives as authorized pursuant to section 1
of P.L.2023, c.2 (C.45:14-67.9), with no requirement to obtain a prescription
or provider order.</u>  The Commissioner of Human Services shall apply for such
State plan amendments or waivers as may be necessary to implement the
provisions of this section and to secure federal financial participation for
State Medicare expenditures under the federal Medicaid program.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2021, c.376, s.11) </p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     10.  This act shall take
effect on the 90th day next following enactment and shall apply to policies and
contracts that are delivered, issued, executed, or renewed on or after that
date.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     This bill clarifies certain current
law regarding coverage for over-the-counter contraceptive drugs by insurers
authorized to provide health benefits in the State.  Specifically, the bill
clarifies that various insurers are required to provide coverage for either the
requested prescriptive contraceptive drugs, devices, and products approved by
the U.S. Food and Drug Administration or the therapeutic equivalents.  Medical
necessity for over-the-counter contraceptive drugs is also deemed to be present
under the coverage of the various health insurers in the State.  Additionally, point-of-sale
coverage for over-the-counter female contraceptives is to be provided without
cost-sharing or medical management restrictions.  Lastly, the bill further
delineates the type of family planning programs that provide benefits for
contraceptives and establishes that Medicaid and the other family planning
programs are to provide coverage for over-the-counter contraceptives and
pharmacy-furnished self-administered hormonal contraceptives with no
requirement for a prescription or provider order.   </p>

</div>

</body>

</html>
